CPX-351 Therapy for MDS After Hypomethylating Agent Failure

Clinical trial NCT03957876 · TERMINATED

Trial details

NCT number: NCT03957876
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2019-07-25
Primary completion: 2022-12-20
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.